viernes, 2 de noviembre de 2018

Symkevi Approved for CF Patients in EU with 2 F508del Mutations, or 1 Plus a Minimal Function Mutation

Symkevi Approved for CF Patients in EU with 2 F508del Mutations, or 1 Plus a Minimal Function Mutation

Cystic Fibrosis News Today

Symkevi Approved in EU for CF Patients with Two F508del Mutations, or One Plus a Minimal Function Mutation

 NOVEMBER 2, 2018
Ana PenaBY ANA PENA
 
IN CYSTIC FIBROSIS, NEWS.
Symkevi Approved in EU for CF Patients with Two F508del Mutations, or One Plus a Minimal Function Mutation
en

No hay comentarios:

Publicar un comentario